Premium
Effect of Local Injection of Cysteamine and Cystamine on Somatostatin and Neuropeptide Y Levels in the Rat Striatum
Author(s) -
Widmann Rudolf,
Maas Dagmar,
Sperk Günther
Publication year - 1988
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1988.tb02463.x
Subject(s) - cysteamine , somatostatin , cystamine , neuropeptide , striatum , chemistry , medicine , endocrinology , neuropeptide y receptor , biochemistry , biology , dopamine , receptor
Cysteamine and its dimeric form cystamine have been applied to the rat striatum by local injection. Both compounds resulted in a dose‐dependent decrease of somatostatin levels. Maximal reduction of somatostatin (by about 50%) was obtained at a dose of 50 μg of cysteamine or cystamine after about 6 h. All three molecular weight forms of somatostatin—somatostatin‐14, somatostatin‐28, and the 13,000 molecular weight form of somatostatin—were reduced, as shown by size exclusion HPLC. Injection of radiolabeled cystamine revealed a fast conversion of the compound to cysteamine, suggesting it is active in the monomeric form. The levels of neuropeptide Y, which is colocalized with somatostatin in striatal neurons, failed to be changed by local or intraperitoneal injection of cysteamine, suggesting that this treatment does not affect vesicles of somatostatin/neuropeptide Y neurons.